11/14/2024
7:42 AM | Esperion Therapeutics (Subject)
Two Seas Capital LP (Filed by)
| Form SC 13G/A | |
11/12/2024
1:23 PM | Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/07/2024
3:22 PM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:22 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
12:33 PM | Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
11:09 AM | Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G | |
|
10/18/2024
3:08 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2024
3:34 PM | Esperion Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
10/17/2024
2:25 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:11 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:12 PM | Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
2:20 PM | Esperion Therapeutics (Subject)
Koenig Sheldon L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/17/2024
2:28 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
3:33 PM | Esperion Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/12/2024
3:08 PM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
6:21 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
7:29 AM | Esperion Therapeutics (Issuer)
Foody Joanne M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
7:30 AM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
2:22 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024
2:11 PM | Esperion Therapeutics (Subject)
Foody Joanne M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2024
7:03 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
3:16 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:20 PM | Esperion Therapeutics (Issuer)
Foody Joanne M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
2:09 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024
2:19 PM | Esperion Therapeutics (Subject)
Foody Joanne M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024
3:26 PM | Esperion Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G | |
05/28/2024
3:16 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
2:08 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
7:50 AM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
6:29 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
3:21 PM | Esperion Therapeutics (Filer)
| Form DEF 14A | |
04/11/2024
3:19 PM | Esperion Therapeutics (Filer)
| Form ARS | |
03/15/2024
3:30 PM | Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:32 PM | Esperion Therapeutics (Issuer)
Halladay Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:33 PM | Esperion Therapeutics (Issuer)
Looker Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:34 PM | Esperion Therapeutics (Issuer)
Foody Joanne M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:35 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
8:19 AM | Esperion Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2024
6:23 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
1:14 PM | CVI Investments, Inc. (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A | |
[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad) All of our key indicators are flashing the same signal: an altcoin season is fast approaching.
And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin |
02/14/2024
9:50 AM | Esperion Therapeutics (Subject)
Two Seas Capital LP (Filed by)
| Form SC 13G/A | |
02/14/2024
7:42 AM | Deep Track Capital, LP (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
5:11 AM | Esperion Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
01/24/2024
2:46 PM | BB BIOTECH AG (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A | |
01/24/2024
2:21 PM | BB BIOTECH AG (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A | |
01/22/2024
5:04 AM | Esperion Therapeutics (Filer)
| Form 424B5 | |
01/22/2024
5:10 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2024
4:01 PM | Esperion Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
01/11/2024
3:09 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
10:02 AM | Esperion Therapeutics (Subject)
Meditor Group Ltd (Filed by)
| Form SC 13G/A | |
01/03/2024
7:00 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free ESPR Stock Alerts